PubMed:18816083 / 0-242 JSONTXT

Annnotations TAB JSON ListView MergeView

    GlyCosmos600-CLO

    {"project":"GlyCosmos600-CLO","denotations":[{"id":"T1","span":{"begin":75,"end":80},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T2","span":{"begin":176,"end":181},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing.\nThere is a correlation between the multidrug-resistance (MDR) of cancer cells and their enhanced invasive or metastatic potential. We stud"}

    sentences

    {"project":"sentences","denotations":[{"id":"TextSentencer_T1","span":{"begin":0,"end":103},"obj":"Sentence"},{"id":"TextSentencer_T2","span":{"begin":104,"end":234},"obj":"Sentence"},{"id":"T1","span":{"begin":0,"end":103},"obj":"Sentence"},{"id":"T2","span":{"begin":104,"end":234},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing.\nThere is a correlation between the multidrug-resistance (MDR) of cancer cells and their enhanced invasive or metastatic potential. We stud"}

    GlyCosmos600-FMA

    {"project":"GlyCosmos600-FMA","denotations":[{"id":"T1","span":{"begin":75,"end":80},"obj":"Body_part"},{"id":"T2","span":{"begin":176,"end":181},"obj":"Body_part"}],"attributes":[{"id":"A1","pred":"fma_id","subj":"T1","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A2","pred":"fma_id","subj":"T2","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing.\nThere is a correlation between the multidrug-resistance (MDR) of cancer cells and their enhanced invasive or metastatic potential. We stud"}

    pubmed-enju-pas

    {"project":"pubmed-enju-pas","denotations":[{"id":"EnjuParser_T0","span":{"begin":0,"end":8},"obj":"NN"},{"id":"EnjuParser_T1","span":{"begin":9,"end":17},"obj":"NN"},{"id":"EnjuParser_T2","span":{"begin":18,"end":20},"obj":"IN"},{"id":"EnjuParser_T3","span":{"begin":21,"end":30},"obj":"JJ"},{"id":"EnjuParser_T4","span":{"begin":31,"end":41},"obj":"NN"},{"id":"EnjuParser_T5","span":{"begin":42,"end":44},"obj":"IN"},{"id":"EnjuParser_T6","span":{"begin":45,"end":50},"obj":"JJ"},{"id":"EnjuParser_T7","span":{"begin":51,"end":55},"obj":"JJ"},{"id":"EnjuParser_T8","span":{"begin":56,"end":64},"obj":"JJ"},{"id":"EnjuParser_T9","span":{"begin":65,"end":74},"obj":"NN"},{"id":"EnjuParser_T10","span":{"begin":75,"end":80},"obj":"NNS"},{"id":"EnjuParser_T11","span":{"begin":81,"end":86},"obj":"VBG"},{"id":"EnjuParser_T12","span":{"begin":87,"end":92},"obj":"NN"},{"id":"EnjuParser_T13","span":{"begin":93,"end":102},"obj":"NN"},{"id":"EnjuParser_T14","span":{"begin":104,"end":109},"obj":"EX"},{"id":"EnjuParser_T15","span":{"begin":110,"end":112},"obj":"VBZ"},{"id":"EnjuParser_T16","span":{"begin":113,"end":114},"obj":"DT"},{"id":"EnjuParser_T17","span":{"begin":115,"end":126},"obj":"NN"},{"id":"EnjuParser_T18","span":{"begin":127,"end":134},"obj":"IN"},{"id":"EnjuParser_T19","span":{"begin":135,"end":138},"obj":"DT"},{"id":"EnjuParser_T20","span":{"begin":139,"end":159},"obj":"JJ"},{"id":"EnjuParser_T21","span":{"begin":160,"end":161},"obj":"-LRB-"},{"id":"EnjuParser_T22","span":{"begin":161,"end":164},"obj":"NN"},{"id":"EnjuParser_T23","span":{"begin":164,"end":165},"obj":"-RRB-"},{"id":"EnjuParser_T24","span":{"begin":166,"end":168},"obj":"IN"},{"id":"EnjuParser_T25","span":{"begin":169,"end":175},"obj":"NN"},{"id":"EnjuParser_T26","span":{"begin":176,"end":181},"obj":"NNS"},{"id":"EnjuParser_T27","span":{"begin":182,"end":185},"obj":"CC"},{"id":"EnjuParser_T28","span":{"begin":186,"end":191},"obj":"PRP-DOLLAR-"},{"id":"EnjuParser_T29","span":{"begin":192,"end":200},"obj":"VBN"},{"id":"EnjuParser_T30","span":{"begin":201,"end":209},"obj":"JJ"},{"id":"EnjuParser_T31","span":{"begin":210,"end":212},"obj":"CC"},{"id":"EnjuParser_T32","span":{"begin":213,"end":223},"obj":"JJ"},{"id":"EnjuParser_T33","span":{"begin":224,"end":233},"obj":"NN"},{"id":"EnjuParser_T34","span":{"begin":235,"end":237},"obj":"PRP"}],"relations":[{"id":"EnjuParser_R0","pred":"arg1Of","subj":"EnjuParser_T1","obj":"EnjuParser_T0"},{"id":"EnjuParser_R1","pred":"arg1Of","subj":"EnjuParser_T1","obj":"EnjuParser_T2"},{"id":"EnjuParser_R2","pred":"arg2Of","subj":"EnjuParser_T4","obj":"EnjuParser_T2"},{"id":"EnjuParser_R3","pred":"arg1Of","subj":"EnjuParser_T4","obj":"EnjuParser_T3"},{"id":"EnjuParser_R4","pred":"arg1Of","subj":"EnjuParser_T4","obj":"EnjuParser_T5"},{"id":"EnjuParser_R5","pred":"arg2Of","subj":"EnjuParser_T10","obj":"EnjuParser_T5"},{"id":"EnjuParser_R6","pred":"arg1Of","subj":"EnjuParser_T10","obj":"EnjuParser_T6"},{"id":"EnjuParser_R7","pred":"arg1Of","subj":"EnjuParser_T10","obj":"EnjuParser_T7"},{"id":"EnjuParser_R8","pred":"arg1Of","subj":"EnjuParser_T10","obj":"EnjuParser_T8"},{"id":"EnjuParser_R9","pred":"arg1Of","subj":"EnjuParser_T10","obj":"EnjuParser_T9"},{"id":"EnjuParser_R10","pred":"arg1Of","subj":"EnjuParser_T1","obj":"EnjuParser_T11"},{"id":"EnjuParser_R11","pred":"arg2Of","subj":"EnjuParser_T13","obj":"EnjuParser_T11"},{"id":"EnjuParser_R12","pred":"arg1Of","subj":"EnjuParser_T13","obj":"EnjuParser_T12"},{"id":"EnjuParser_R13","pred":"arg1Of","subj":"EnjuParser_T14","obj":"EnjuParser_T15"},{"id":"EnjuParser_R14","pred":"arg2Of","subj":"EnjuParser_T27","obj":"EnjuParser_T15"},{"id":"EnjuParser_R15","pred":"arg1Of","subj":"EnjuParser_T17","obj":"EnjuParser_T16"},{"id":"EnjuParser_R16","pred":"arg1Of","subj":"EnjuParser_T17","obj":"EnjuParser_T18"},{"id":"EnjuParser_R17","pred":"arg2Of","subj":"EnjuParser_T20","obj":"EnjuParser_T18"},{"id":"EnjuParser_R18","pred":"arg1Of","subj":"EnjuParser_T20","obj":"EnjuParser_T19"},{"id":"EnjuParser_R19","pred":"arg1Of","subj":"EnjuParser_T20","obj":"EnjuParser_T21"},{"id":"EnjuParser_R20","pred":"arg2Of","subj":"EnjuParser_T22","obj":"EnjuParser_T21"},{"id":"EnjuParser_R21","pred":"arg3Of","subj":"EnjuParser_T23","obj":"EnjuParser_T21"},{"id":"EnjuParser_R22","pred":"arg1Of","subj":"EnjuParser_T20","obj":"EnjuParser_T24"},{"id":"EnjuParser_R23","pred":"arg2Of","subj":"EnjuParser_T26","obj":"EnjuParser_T24"},{"id":"EnjuParser_R24","pred":"arg1Of","subj":"EnjuParser_T26","obj":"EnjuParser_T25"},{"id":"EnjuParser_R25","pred":"arg1Of","subj":"EnjuParser_T17","obj":"EnjuParser_T27"},{"id":"EnjuParser_R26","pred":"arg2Of","subj":"EnjuParser_T33","obj":"EnjuParser_T27"},{"id":"EnjuParser_R27","pred":"arg1Of","subj":"EnjuParser_T33","obj":"EnjuParser_T28"},{"id":"EnjuParser_R28","pred":"arg2Of","subj":"EnjuParser_T33","obj":"EnjuParser_T29"},{"id":"EnjuParser_R29","pred":"arg1Of","subj":"EnjuParser_T33","obj":"EnjuParser_T30"},{"id":"EnjuParser_R30","pred":"arg1Of","subj":"EnjuParser_T30","obj":"EnjuParser_T31"},{"id":"EnjuParser_R31","pred":"arg2Of","subj":"EnjuParser_T32","obj":"EnjuParser_T31"},{"id":"EnjuParser_R32","pred":"arg1Of","subj":"EnjuParser_T33","obj":"EnjuParser_T32"}],"namespaces":[{"prefix":"_base","uri":"http://kmcs.nii.ac.jp/enju/"}],"text":"Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing.\nThere is a correlation between the multidrug-resistance (MDR) of cancer cells and their enhanced invasive or metastatic potential. We stud"}

    HP-phenotype

    {"project":"HP-phenotype","denotations":[{"id":"T1","span":{"begin":65,"end":74},"obj":"Phenotype"},{"id":"T2","span":{"begin":169,"end":175},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"HP:0030731"},{"id":"A2","pred":"hp_id","subj":"T2","obj":"HP:0002664"}],"namespaces":[{"prefix":"HP","uri":"http://purl.obolibrary.org/obo/HP_"}],"text":"Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing.\nThere is a correlation between the multidrug-resistance (MDR) of cancer cells and their enhanced invasive or metastatic potential. We stud"}

    mondo_disease

    {"project":"mondo_disease","denotations":[{"id":"T1","span":{"begin":56,"end":74},"obj":"Disease"},{"id":"T2","span":{"begin":169,"end":175},"obj":"Disease"}],"attributes":[{"id":"A1","pred":"mondo_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/MONDO_0005096"},{"id":"A2","pred":"mondo_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/MONDO_0004992"}],"text":"Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing.\nThere is a correlation between the multidrug-resistance (MDR) of cancer cells and their enhanced invasive or metastatic potential. We stud"}

    NCBITAXON

    {"project":"NCBITAXON","denotations":[{"id":"T1","span":{"begin":45,"end":50},"obj":"OrganismTaxon"}],"attributes":[{"id":"A1","pred":"db_id","subj":"T1","obj":"9606"}],"text":"Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing.\nThere is a correlation between the multidrug-resistance (MDR) of cancer cells and their enhanced invasive or metastatic potential. We stud"}

    CL-cell

    {"project":"CL-cell","denotations":[{"id":"T1","span":{"begin":169,"end":181},"obj":"Cell"}],"attributes":[{"id":"A1","pred":"cl_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/CL:0001064"}],"text":"Proteome analysis of multidrug resistance of human oral squamous carcinoma cells using CD147 silencing.\nThere is a correlation between the multidrug-resistance (MDR) of cancer cells and their enhanced invasive or metastatic potential. We stud"}